Segment Information (Tables)
|3 Months Ended|
Mar. 31, 2022
|Schedule of Segment Information||
The Company operates in two reportable segments, Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The accounting policies of the Company are consistently applied to all segments. The following tables summarize, for the periods indicated, operating results from continued operations by reportable segment:
Note 1: Dermatology Product Sales segment reflects stand-alone income tax expense that has been eliminated in consolidation.
The following tables summarize, for the periods indicated, total assets by reportable segment:
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef